Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 148
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Viral Hepat ; 18(11): 768-78, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20723035

RESUMEN

The outcome of hepatitis C virus (HCV) infection and the likelihood of a sustained virological response (SVR) to antiviral therapy depends on both viral and host characteristics. In vitro studies demonstrated that bile acids (BA) interfere with antiviral interferon effects. We investigate the influence of plasma BA concentrations and an ABCB11 polymorphism associated with lower transporter expression on viral load and SVR. Four hundred and fifty-one Caucasian HCV-patients treated with PEG-interferon and ribavirin were included in the study. ABCB11 1331T>C was genotyped, and plasma BA levels were determined. The 1331C allele was slightly overrepresented in HCV-patients compared to controls. In HCV-patients, a significant difference between patients achieving SVR vs non-SVR was observed for HCV-2/3 (5 vs 9 µm; P=0.0001), while median BA levels in HCV-1 were marginally elevated. Normal BA levels <8 µm were significantly associated with SVR (58.3%vs 36.3%; OR 2.48; P=0.0001). This difference was significant for HCV-2/3 (90.7%vs 67.6%; P=0.002) but marginal in HCV-1 (38.7%vs 27.8%; P=0.058). SVR rates were equivalent between ABCB11 genotypes for HCV-1, but increased for HCV-2/3 (TT 100%vs CC 78%; OR 2.01; P=0.043). IL28B genotype had no influence on these associations. No correlation between BA levels and HCV RNA was detected for any HCV genotype. The higher allelic frequency of ABCB11 1331C in HCV-patients compared to controls may indirectly link increased BA to HCV chronicity. Our data support a role for BA as host factor affecting therapy response in HCV-2/3 patients, whereas a weaker association was found for HCV-1.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/genética , Antivirales/uso terapéutico , Ácidos y Sales Biliares/sangre , Hepacivirus/efectos de los fármacos , Hepatitis C Crónica/tratamiento farmacológico , Polimorfismo de Nucleótido Simple , Miembro 11 de la Subfamilia B de Transportador de Casetes de Unión al ATP , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Quimioterapia Combinada , Femenino , Genotipo , Hepatitis C Crónica/genética , Hepatitis C Crónica/virología , Humanos , Interferón-alfa/antagonistas & inhibidores , Interferón-alfa/uso terapéutico , Masculino , Persona de Mediana Edad , Polietilenglicoles/uso terapéutico , Proteínas Recombinantes/antagonistas & inhibidores , Proteínas Recombinantes/uso terapéutico , Ribavirina/administración & dosificación , Ribavirina/uso terapéutico , Resultado del Tratamiento
2.
Transpl Infect Dis ; 13(4): 416-8, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21615846

RESUMEN

Diarrhea in a transplant recipient may be caused by infection, metabolic problems, or adverse drug effects. The immunosuppressive drug most frequently associated with diarrhea in transplant recipients is mycophenolate mofetil (MMF). We present the case of a patient with 2 potential explanations for diarrhea lasting several weeks, which occurred years after liver transplantation. Whereas stool samples were positive for cryptosporidia, the histopathological findings were compatible with MMF colitis. However, diarrhea resolved after treatment of cryptosporidial infection, despite continued MMF medication. This case shows that histopathological findings of MMF colitis may be misleading and do not prove that diarrhea is drug induced.


Asunto(s)
Criptosporidiosis/tratamiento farmacológico , Cryptosporidium/aislamiento & purificación , Diarrea/tratamiento farmacológico , Inmunosupresores/efectos adversos , Trasplante de Hígado/efectos adversos , Ácido Micofenólico/análogos & derivados , Adulto , Animales , Criptosporidiosis/diagnóstico , Criptosporidiosis/parasitología , Cryptosporidium/efectos de los fármacos , Diarrea/inducido químicamente , Diarrea/parasitología , Humanos , Inmunosupresores/uso terapéutico , Masculino , Ácido Micofenólico/efectos adversos , Ácido Micofenólico/uso terapéutico , Paromomicina/uso terapéutico , Resultado del Tratamiento
3.
Swiss Med Wkly ; 139(5-6): 70-5, 2009 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-19204839

RESUMEN

BACKGROUND: Ambrosia artemisiifolia (short name = Ambrosia common ragweed) pollen is a potent allergen and has recently been found in Switzerland, spreading from the southwest of the country. The aim of this study is to describe Ambrosia sensitisation rates in the population-based SAPALDIA cohort (Swiss Study on Air Pollution And Lung Diseases In Adults) and to test whether an increase in these rates could be observed. METHODS: Among the 6345 participants from 8 areas who provided blood samples in 1991 and 2002, 5823 had valid results for specific IgE against common inhalant allergens tested with Phadiatop. In 2002 Ambrosia sensitisation was measured and positive tests were analysed for Artemisia vulgaris (mugwort). Blood samples taken in 1991 in Ticino and Geneva were also tested for Ambrosia. RESULTS: Sensitisation rate (Phadiatop) did not increase significantly between the two surveys and sensitisation was found in 30% of the participants. A proportion of 7.9% showed specific IgE to Ambrosia pollen. The sensitisation rate in Lugano and Geneva had not changed substantially since 1991. Among those sensitised to Ambrosia 82% also showed specific IgE against Artemisia, suggesting a high rate of cross-reactivity. Only 1.3% were sensitized to Ambrosia alone. The incidence of asthma or hay fever in participants with specific IgE to Ambrosia pollen was not higher than in the general study population. CONCLUSION: Currently Ambrosia pollen does not appear to be an important cause of inhalant allergies in Switzerland. Sensitisation rates are low and have not increased since 1991. Due to cross-reactivity Ambrosia sensitisation may be a consequence of primary sensitisation to Artemisia. Elimination of Ambrosia plants is nevertheless mandatory to avoid a future increase.


Asunto(s)
Ambrosia/inmunología , Rinitis Alérgica Estacional/epidemiología , Adulto , Artemisia/inmunología , Asma/epidemiología , Reacciones Cruzadas/inmunología , Humanos , Inmunización , Inmunoglobulina E/inmunología , Persona de Mediana Edad , Salud Pública , Suiza/epidemiología
4.
Ther Umsch ; 63(12): 763-6, 2006 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-17133297

RESUMEN

Steroid therapy increases the risk of bowel perforation. Bowel perforation may occur at any time of steroid therapy, but the first weeks appear to hold the greatest potential for perforation. However, clinical findings after perforation may be misleading under steroids, and peritonitis may be absent. It is known that bowel perforation can lead to subcutaneous emphysema at various sites. Thus, in any patient with emphysema, bowel perforation must be included in the differential diagnosis, especially in patients receiving steroids. Missing knowledge of this entity may lead to marked delay between onset of initial signs and diagnosis, and hence worsen the survival rate. In this report we present a case of chronic steroid use, where asymptomatic sigma perforation led to a generalized emphysema, which was initially attributed to a maxillary sinus infection due to Aspergillus and anaerobic bacteria.


Asunto(s)
Aspergilosis/diagnóstico , Aspergillus niger , Enfermedades Autoinmunes/tratamiento farmacológico , Inmunosupresores/efectos adversos , Perforación Intestinal/inducido químicamente , Perforación Intestinal/diagnóstico , Sinusitis Maxilar/diagnóstico , Enfermedades Musculares/tratamiento farmacológico , Micetoma/diagnóstico , Prednisolona/efectos adversos , Prednisona/efectos adversos , Enfermedades del Sigmoide/inducido químicamente , Enfermedades del Sigmoide/diagnóstico , Enfisema Subcutáneo/etiología , Anciano de 80 o más Años , Infecciones por Bacteroides/diagnóstico , Diagnóstico Diferencial , Resultado Fatal , Humanos , Inmunosupresores/administración & dosificación , Cuidados a Largo Plazo , Masculino , Prednisolona/administración & dosificación , Prednisona/administración & dosificación , Sobreinfección/diagnóstico , Tomografía Computarizada por Rayos X
5.
J Neurosci Methods ; 45(3): 155-8, 1992 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1294850

RESUMEN

A modification of a commercially available digital-audio tape (DAT) for DC recordings such as those used in patch clamp and other electrophysiological experiments is introduced. The modified DAT can record data from 2 channels plus a separate trigger signal for up to 2 h. The bandwidth ranges from direct current to 21 kHz; the signal-to-noise ratio is above 90 dB and the A-D resolution is 16 bit. A 120-min cassette yields a storage capacity of 1.4 Gbytes. The trigger is 'hidden' on 1 channel as a burst of 1-ms duration, thus minimizing interference with the recorded data. The modified DAT offers a low-cost yet high quality solution to most analog data storage needs.


Asunto(s)
Electrofisiología/instrumentación , Grabación en Cinta/instrumentación , Amplificadores Electrónicos , Electrónica
6.
Brain Res ; 311(2): 361-5, 1984 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-6149789

RESUMEN

Animals with 6-hydroxydopamine-induced partial unilateral lesions of the substantia nigra exhibit spontaneous recovery from motor asymmetry, a transitory increase in dopamine turnover and an increase in tyrosine hydroxylase activity in the denervated striatum. The recovery of function in these animals seems to be due to the compensatory increase in dopamine metabolism as well as due to the time-dependent increase in tyrosine hydroxylase resulting from either enzyme activation or following reinnervation of the denervated striatum by nigral efferents spared by the partial lesions.


Asunto(s)
Hidroxidopaminas/farmacología , Actividad Motora/efectos de los fármacos , Sustancia Negra/fisiología , Ácido 3,4-Dihidroxifenilacético/metabolismo , Anfetamina/farmacología , Animales , Apomorfina/farmacología , Dopamina/metabolismo , Femenino , Lateralidad Funcional , Ácido Homovanílico/metabolismo , Oxidopamina , Ratas , Ratas Endogámicas , Sustancia Negra/efectos de los fármacos , Sustancia Negra/metabolismo , Tirosina 3-Monooxigenasa/metabolismo
7.
Anticancer Res ; 17(4B): 2915-8, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9329562

RESUMEN

The clinical evaluation of the Cobas Core beta 2-Microglobulin EIA was performed on the random access analyzer Cobas Core. The coefficients of variations for the intra-assay and inter-assay precisions ranged between 3% and 6%. In comparison to healthy persons (0.7-2.7 mg/l), significantly elevated serum levels of beta 2-m were found in patients with lymphoproliferative disorders like monoclonal gammopathies of the IgG (1.98-78 mg/l; p = 0.0001), IgA (1.3-7.1 mg/l; p = 0.0002) and of the IgM (2.1-8.7 mg/l; p = 0.0001) type, in malignant lymphoma (1.5-33.5 mg/l; p = 0.0001) and in chronic lymphatic leukemia (1.5-22.4 mg/l; p = 0.0001). In cases of HIV-infection, increasing levels of beta 2-m exhibited an inverse correlation to the CD4+ T-lymphocyte count (p = 0.0001) and indicated disease progression. In patients having renal transplantation a rejection of the graft was accompanied by a rise of the beta 2-m serum level. In summary, the data clearly indicate the reliability of the measuring system as well as the clinical relevance of beta-2-M determinations for such patient groups.


Asunto(s)
Microglobulina beta-2/análisis , Recuento de Linfocito CD4 , Humanos , Técnicas para Inmunoenzimas
8.
Arch Dermatol Res ; 275(6): 359-64, 1983.
Artículo en Inglés | MEDLINE | ID: mdl-6318671

RESUMEN

This review is an attempt to discuss the basic conceptual tools that are a prerequisite for any clinical study of chemotactic defects. They include familiarity with definitions of common terms and with the merits and drawbacks of the several possible in vivo and in vitro assay methods. Cellular mechanisms involved in locomotion are complex. They include basic requirements for cell metabolism as well as receptor recognition, attachment to surfaces and contraction of the cytoskeleton of the cell. Of the many chemotactic factors reported, few are well characterized and universally agreed upon. Similarly, with the use of more stringent criteria, a number of clinical defects of chemotaxis have proven transitory or even artifactual.


Asunto(s)
Quimiotaxis de Leucocito , Técnicas Inmunológicas , Enfermedades de la Piel/inmunología , Adulto , Animales , Movimiento Celular , Factores Quimiotácticos/fisiología , Quimiotaxis de Leucocito/efectos de los fármacos , Enfermedades del Colágeno/inmunología , Enfermedades del Colágeno/patología , Complemento C5/biosíntesis , Complemento C5/fisiología , Complemento C5a , Granulocitos/inmunología , Granulocitos/fisiología , Cobayas , Humanos , Enfermedades Metabólicas/inmunología , Enfermedades Metabólicas/patología , N-Formilmetionina Leucil-Fenilalanina/fisiología , Disfunción de Fagocito Bactericida/inmunología , Disfunción de Fagocito Bactericida/patología , Fagocitosis , Receptores de Superficie Celular , Receptores de Formil Péptido , Enfermedades de la Piel/patología
9.
Inflammation ; 8(4): 417-27, 1984 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-6394496

RESUMEN

The effect of amoxycillin and doxycycline on human granulocyte function was studied in vitro. The antimicrobial agents were added to tests of chemotaxis, random motility, yeast phagocytosis, and killing, at progressing concentrations. The effect was also evaluated in vivo by measuring chemotaxis and random motility (agarose technique) of granulocytes from rabbits injected with these antibiotics. Amoxycillin was shown to have a slightly stimulating effect on chemotaxis, demonstrable only at the highest concentration tested (100 micrograms/ml), and no effect on the other variables. Doxycycline had a dose-related inhibitory effect on chemotaxis, random motility, and phagocytosis, and no effect on killing. Chemotaxis and random motility were slightly, but not significantly, stimulated in vivo when rabbits were given amoxycillin. Chemotaxis (but not random motility) was significantly impaired when the rabbits were given doxycycline.


Asunto(s)
Amoxicilina/farmacología , Quimiotaxis de Leucocito/efectos de los fármacos , Doxiciclina/farmacología , Granulocitos/efectos de los fármacos , Animales , Humanos , Fagocitosis/efectos de los fármacos , Conejos , Saccharomyces cerevisiae
10.
Artículo en Inglés | MEDLINE | ID: mdl-7921328

RESUMEN

The Immunodot CMG is a new, simple assay for the semiquantitative screening of specific IgE. It does not necessitate any particular equipment. It consists of two nitrocellulose strips on which either five indoor or five outdoor allergens are bound. In the present evaluation, 82 serum samples from allergic patients were tested with the first strip and 101 with the second. The results were compared with those obtained with the CAP System (Kabi Pharmacia). A version using undiluted serum and a short incubation time (short version) appeared to be more sensitive than a long version using serum diluted 1:5. In most cases, the results agreed with those of the CAP System. Discordant results were found in 2-9% of the cases according to the allergen, and were most often negative with Immunodot CMG and positive with the CAP System, indicating a slightly lower sensitivity for the new test. When compared to the CAP System, the Immunodot CMG showed a sensitivity of 84.5% and a specificity of 94%. Readings were found to be reproducible and easy to perform with the naked eye. Our results showed that the Immunodot CMG test is comparable to the CAP System, which is slightly more sensitive but requires much more elaborate and expensive equipment.


Asunto(s)
Immunoblotting/métodos , Inmunoglobulina E/inmunología , Alérgenos/inmunología , Especificidad de Anticuerpos , Humanos , Hipersensibilidad Inmediata/diagnóstico , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
11.
Prev Vet Med ; 32(1-2): 1-21, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9361316

RESUMEN

A prospective longitudinal observational study based on a stratified random sample of 113 Swiss dairy farms was conducted between April 1993 and July 1994 with the following objectives: (i) to provide statistically valid estimates of disease frequency in the Swiss dairy cow population, and (ii) to evaluate the feasibility and quality of an intensive farm-based data recording system. During the 15-month study period, farmers were asked to record every health and management event related to their cattle herd. This information was mailed back to the study centre at fortnightly intervals. Additionally, farms were visited regularly to verify received data and to discuss specific problems. During these farm visits, management data were recorded using questionnaires. A complete data set of individual animal events with a total observation time of about 1740 cow-years and 275 calf-years was collected and disease-incidence measures were calculated. The most frequent events were reproductive disorders and udder diseases, followed by lameness and metabolic disorders. Experience with the data collection technique used in this study suggests that a farm-based system is effective and reliable, as long as good contact with the farmers is maintained, and incentives to stimulate their motivation are provided.


Asunto(s)
Enfermedades de los Bovinos/epidemiología , Crianza de Animales Domésticos , Animales , Bovinos , Métodos Epidemiológicos/veterinaria , Femenino , Incidencia , Estudios Longitudinales , Embarazo , Suiza/epidemiología
12.
Soz Praventivmed ; 43 Suppl 1: S5-9, S79-83, 1998.
Artículo en Francés, Alemán | MEDLINE | ID: mdl-9833255

RESUMEN

The hepatitis B virus belongs to the hepadna viruses family. Its genome consists of an incompletely double stranded DNA. The preS/S domain encodes proteins which make up the outer viral coat containing the HBs surface antigen (HBsAg). Other viral genes programme for structures inside the virus and for various regulatory enzymes. HBV mainly infects hepatocytes. The virus replicates in the cytoplasm and is primarily non-cytopathogenic. HBV can also integrate into the host cell. Various stable genotypes and subtypes are known, which have a characteristic geographic distribution. They all share a common HBsAg epitop, which has allowed the development of a vaccine which is efficient world-wide. The protective principle consists of inducing protective anti-HBs. The infected cell has to be destroyed to eliminate the virus. Cellular immune defence mechanisms are mainly relevant, the principle effectors being cytotoxic T lymphocytes, activated monocytes/macrophages and cytokines such as interferon-gamma. The natural course of infection is highly variable, comprising viral elimination with or without acute hepatitis and chronic infection which might lead to chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. This is due to the balance respectively to the inbalance between the viral replication capacity and the immune defence mechanisms.


Asunto(s)
Virus de la Hepatitis B/genética , Hepatitis B/virología , Adulto , Transformación Celular Neoplásica/genética , Niño , Hepatitis B/inmunología , Anticuerpos contra la Hepatitis B/sangre , Antígenos de Superficie de la Hepatitis B/inmunología , Virus de la Hepatitis B/inmunología , Humanos , Hígado/inmunología , Hígado/virología , Neoplasias Hepáticas/genética , Replicación Viral/genética
13.
Soz Praventivmed ; 43 Suppl 1: S10-3, S84-7, 1998.
Artículo en Francés, Alemán | MEDLINE | ID: mdl-9833256

RESUMEN

This paper is a short summary on the usefulness of two antigens (HBsAg and HBeAg), three antibodies (anti-HBc, anti-HBe and anti-HBs) and of HBV DNA, as markers for the diagnosis and the follow-up of hepatitis B. The significance of each of these markers at the various stages of disease history, a few patterns of co-existence of some of these markers and the occurrence of mutations in the core and pre-core regions of the genome are also described. The various indications for measuring HBV DNA, in addition to the classical serological markers, are also mentioned.


Asunto(s)
Anticuerpos contra la Hepatitis B/sangre , Antígenos de la Hepatitis B/sangre , Hepatitis B/diagnóstico , Estudios de Seguimiento , Hepatitis B/inmunología , Humanos
14.
Schweiz Arch Tierheilkd ; 139(8): 343-53, 1997.
Artículo en Alemán | MEDLINE | ID: mdl-9297231

RESUMEN

Between July 1993 and July 1994 morbidity and management information related to dairy cows and their calves up to the age of 8 weeks were recorded in 113 randomly selected dairy herds. Also recorded were any costs incurred through disease and prevention. Blood and faeces were analysed with respect to selected pathogens. The health problems most frequently diagnosed in cows were reproductive and udder diseases. Calves suffered most often from diarrhea, omphalitis and pneumonia. The directly disease-related costs per cow-year on average amounted to CHF 139.44 and CHF 4.18 per calf. For prevention, farmers spent on average CHF 10.18 per cow-year. Results from the laboratory analyses indicate that in 68.1% of the farms antibodies against Leptospira hardjo and in 61.9% against Coxiella burnetii were detected. In 8.0% of the farms antibodies against Mycobacterium paratuberculosis were found. Antibodies against BVD virus was present in 99.4% of the farms. Cows from 63.7% farms were infected with gastrointestinal strongylids. Veterinary assistance was required on average 1.96 times per cow-year. In almost all reproductive and puerperal disease cases a veterinarian was consulted while lameness in the majority of cases was treated by the owner. The veterinary profession was hardly ever involved in disease prevention.


Asunto(s)
Enfermedades de los Bovinos/economía , Enfermedades de los Bovinos/epidemiología , Animales , Animales Recién Nacidos , Bovinos , Estudios de Cohortes , Enfermedades Transmisibles/economía , Enfermedades Transmisibles/epidemiología , Enfermedades Transmisibles/veterinaria , Diarrea/economía , Diarrea/epidemiología , Diarrea/veterinaria , Femenino , Enfermedades de los Genitales Femeninos/economía , Enfermedades de los Genitales Femeninos/epidemiología , Enfermedades de los Genitales Femeninos/veterinaria , Incidencia , Mastitis Bovina/economía , Mastitis Bovina/epidemiología , Neumonía/economía , Neumonía/epidemiología , Neumonía/veterinaria , Embarazo , Complicaciones del Embarazo/economía , Complicaciones del Embarazo/epidemiología , Complicaciones del Embarazo/veterinaria , Suiza/epidemiología
15.
Neurogastroenterol Motil ; 25(6): 467-73, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23495824

RESUMEN

BACKGROUND: To evaluate the correlation between the levels of C-reactive protein (CRP), calprotectin, and small bowel motility in patients with Crohn's disease assessed with MRI. METHODS: This prospective institutional review board approved study included magnetic resonance imaging enterography (MRE) and analyses of inflammatory markers in blood (C-reactive protein) and feces (calprotectin). For cine MRE, a coronal 2D-T2w sequence was used on a 1.5 T MRI system. Small bowel motility was analyzed in 13 patients using dedicated magnetic resonance MR-motility assessment software (Motasso). Contraction frequency, amplitude, amplitude diameter ratio, and luminal diameter were determined as well as the blood levels of CRP (mg L(-1) ) and fecal levels of calprotectin (ug g(-1) ). Statistics were calculated using Pearson's correlation coefficient. KEY RESULTS: A significant inverse linear correlation was found between the contraction frequency and both the level of CRP (r = -0.701, P = 0.008) and calprotectin (r = -0.805, P = 0.001). Dilatation of small bowel diameter significantly correlated with calprotectin levels (r = 0.857, P =< 0.001) but not with CRP (r = 0.447, P = 0.126). The absolute amplitude of the contractions did not correlate neither with the level of CRP (r = -0.527, P = 0.064) nor with calprotectin (r = -0.612, P = 0.026). The ratio describing the contraction amplitude relatively to the individual luminal diameter significantly correlated with calprotectin (r = 0.736, P = 0.004) and with CRP (r = 0.577, P = 0.039). CONCLUSIONS & INFERENCES: Alterations of small bowel motility during CD flares significantly correlate with the level of calprotectin and CRP indicating that they represent inflammatory activity.


Asunto(s)
Proteína C-Reactiva/análisis , Enfermedad de Crohn/fisiopatología , Motilidad Gastrointestinal/fisiología , Intestino Delgado/fisiopatología , Complejo de Antígeno L1 de Leucocito/análisis , Adulto , Anciano , Proteína C-Reactiva/metabolismo , Enfermedad de Crohn/metabolismo , Enfermedad de Crohn/patología , Heces/química , Femenino , Humanos , Inflamación/metabolismo , Inflamación/patología , Inflamación/fisiopatología , Intestino Delgado/patología , Complejo de Antígeno L1 de Leucocito/metabolismo , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Índice de Severidad de la Enfermedad
16.
J Chemother ; 22(2): 92-7, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20435567

RESUMEN

The objective of this study was to investigate the pharmacokinetics of cefuroxime in wound secretion and the antibacterial activity of the traumatic wound secretion in patients receiving cefuroxime and in those not receiving antibiotics. Included in the present controlled, prospective, non-randomized study were 12 patients with an open fracture who needed vacuum therapy (group A) and 12 patients with a closed fracture, who, due to soft tissue damage, also underwent treatment with vacuum therapy (group B). Wound secretion was obtained on the first, third and fifth postoperative days and exposed to the test bacteria, Staphylococcus aureus and Staphylococcus epidermidis. Patients in group A underwent systemic antibiotic treatment with cefuroxime administered intravenously at a dose of 1.5 g every 8 hours. Patients in group B did not receive antibiotics. Cefuroxime concentrations were determined using high-performance liquid chromatography (HPLC). Antibacterial activity was determined using the inhibition test. Maximum cefuroxime concentrations in wound secretion were measured at 4-5 hours following intravenous administration and, with a mean concentration of 10 mg/l, remained consistently above the minimum inhibitory concentration (MIC) for the test bacteria at all points during the measurement period. As expected, the antibacterial activity of the wound secretion in patients in group A (cefuroxime) was higher than that in group B (no antibiotics). In group A, antibacterial activity against S. aureus was 94.6% and 100% against S. epidermidis. In group B, antibacterial activity against S. aureus was 61% and 81% against S. epidermidis. Cefuroxime reaches the highest level in wound secretion after 4 hours. The high antibacterial activity of the wound secretion in traumatic closed fractures is elevated by cefuroxime. in addition, our findings show that vacuum therapy of wounds is suitable as a non-invasive method for studying the pharmacokinetics of antibiotics.


Asunto(s)
Antibacterianos/farmacocinética , Antibacterianos/uso terapéutico , Cefuroxima/farmacocinética , Cefuroxima/uso terapéutico , Fracturas Cerradas/terapia , Fracturas Abiertas/terapia , Vacio , Antibacterianos/administración & dosificación , Cefuroxima/administración & dosificación , Cromatografía Líquida de Alta Presión , Fracturas Cerradas/microbiología , Fracturas Abiertas/microbiología , Humanos , Infusiones Intravenosas , Pruebas de Sensibilidad Microbiana , Estudios Prospectivos , Staphylococcus aureus/efectos de los fármacos , Staphylococcus epidermidis/efectos de los fármacos , Infección de Heridas/prevención & control
20.
Arch Gynecol Obstet ; 256(Suppl 1): S276-S278, 1995 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-27696067
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA